FSBI "Russian Oncology Scientific center n.a. N. N. Blokhin" RAMS

Moscow 115478

0 studies enrolling now · 1 studies all time

What they study most

Early Breast Cancer

Studies at this site

• A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04) — Completed